Clinical Trial Offers Evidence That Treating Depression May Prevent Heart Disease Recurrence

April 15, 2010

NEW YORK (April 12, 2010) - A new randomized control trial that examined 157 patients across five hospital sites indicates that, in people who had suffered cardiac events, it might be possible to help prevent future heart disease by treating their depressive symptoms.

The intervention that was tested included patient choice of psychotherapy and/or pharmacotherapy; a form of psychotherapy called problem-solving therapy; and a “stepped care” approach in which symptom severity was reviewed every eight weeks and treatment was augmented accordingly. Enhanced models of depression treatment that consider patient preference and many depression intervention options may offer an effective approach to treat depressive symptoms and improve cardiac prognosis, researchers found.

Karina Davidson, Ph.D. The study was led by Karina Davidson, Ph.D., the Herbert Irving Associate Professor of Medicine & Psychiatry and director of the Center for Behavioral Cardiovascular Health at Columbia University Medical Center, along with many of her colleagues at Columbia. Although this new finding is potentially very exciting, larger trials to determine the best way to manage depression and treat coronary heart disease need to be launched, according to the conclusions published in the lead article of the most recent Archives of Internal Medicine.

“In light of the damaging impact of depression on quality of life and prognosis in cardiac patients, rates of detection and effective treatment for depression remain unacceptably low in cardiac patient populations,” Dr. Davidson said. “It was in this spirit that the trial was undertaken, and our team owes much to the National Institutes of Health for recognizing the potential causal nexus between depression and heart disease, and for funding both this first trial, and a larger trial based on these findings through the American Recovery and Reinvestment Act Grand Opportunities ‘GO’Grant program.”

The study was funded by the National Heart, Lung, and Blood Institute’s Grant #HC25197.


Columbia University Medical Center provides international leadership in basic, pre-clinical and clinical research, in medical and health sciences education, and in patient care. The medical center trains future leaders and includes the dedicated work of many physicians, scientists, public health professionals, dentists, and nurses at the College of Physicians and Surgeons, the Mailman School of Public Health, the College of Dental Medicine, the School of Nursing, the biomedical departments of the Graduate School of Arts and Sciences, and allied research centers and institutions. Established in 1767, Columbia’s College of Physicians & Surgeons was the first institution in the country to grant the M.D. degree and is now among the most selective medical schools in the country. Columbia University Medical Center is home to the largest medical research enterprise in New York City and state and one of the largest in the United States. For more information, please visit


Dental Medicine, future, Internal Medicine, Karina Davidson, Mailman School, New York City